We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
(-4.4%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$41.2M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$30.6M |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$29.6M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.3M |
| 5 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$26.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$46M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$45.2M |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$41.1M |
| 4 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$28.8M |
| 5 |
SPDR Gold Trust
GLD
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.86% |
| 2 | Financials | 4.76% |
| 3 | Consumer Discretionary | 4.5% |
| 4 | Healthcare | 4.18% |
| 5 | Consumer Staples | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Veeva Systems
VEEV
$39.2B
| $10M | 0.06% |
60,950
-8,651
| -12% | -$1.73M |
|
327
Sherwin-Williams
SHW
$87.4B
| $10M | 0.06% |
48,919
-94
| -0.2% | -$22.3K |
|
328
Prudential Financial
PRU
$42.3B
| $9.99M | 0.06% |
116,476
+2,212
| +2% | +$213K |
|
329
Energy Transfer Partners
ET
$72.1B
| $9.97M | 0.06% |
904,196
+62,343
| +7% | +$694K |
|
330
Gilead Sciences
GILD
$168B
| $9.96M | 0.06% |
161,510
+5,043
| +3% | +$318K |
|
|
IFLN
331
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
| $9.84M | 0.06% |
598,638
+14,142
| +2% | +$244K |
|
332
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
| $9.81M | 0.06% |
174,832
+21,178
| +14% | +$1.33M |
|
333
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $9.73M | 0.05% |
197,505
-204,758
| -51% | -$10.3M |
|
|
BSCN
334
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| $9.73M | 0.05% |
466,275
+230,500
| +98% | +$4.83M |
|
335
Invesco Large Cap Growth ETF
PWB
$2.43B
| $9.69M | 0.05% |
170,148
+1,770
| +1% | +$111K |
|
336
DNP Select Income Fund
DNP
$4.12B
| $9.66M | 0.05% |
932,168
+12,616
| +1% | +$141K |
|
337
Nucor
NUE
$61.9B
| $9.64M | 0.05% |
90,120
+9,626
| +12% | +$1.21M |
|
338
John Hancock Multifactor Large Cap ETF
JHML
$1.2B
| $9.56M | 0.05% |
210,551
+22,026
| +12% | +$1.1M |
|
339
Tractor Supply
TSCO
$19B
| $9.55M | 0.05% |
257,010
+3,910
| +2% | +$152K |
|
340
American Express
AXP
$232B
| $9.41M | 0.05% |
69,763
+1,434
| +2% | +$217K |
|
341
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
| $9.37M | 0.05% |
357,113
-18,382
| -5% | -$508K |
|
|
342
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
| $9.33M | 0.05% |
103,634
-413,121
| -80% | -$41.1M |
|
343
FedEx
FDX
$77.3B
| $9.28M | 0.05% |
62,522
-5,091
| -8% | -$1.07M |
|
344
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
| $9.26M | 0.05% |
160,578
+9,477
| +6% | +$583K |
|
345
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.69B
| $9.19M | 0.05% |
259,191
+36,336
| +16% | +$1.46M |
|
346
FT Vest Fund of Buffer ETFs
BUFR
$10.4B
| $9.16M | 0.05% |
439,638
-4,532
| -1% | -$101K |
|
347
FT Vest US Equity Deep Buffer ETF July
DJUL
$457M
| $9.1M | 0.05% |
306,841
+288,372
| +1,561% | +$8.96M |
|
|
HFRO
348
Highland Opportunities and Income Fund
HFRO
$398M
| $9.1M | 0.05% |
935,986
-446,082
| -32% | -$5.1M |
|
349
Elevance Health
ELV
$86.6B
| $9.02M | 0.05% |
19,860
+824
| +4% | +$394K |
|
350
Zoetis
ZTS
$30.4B
| $9.01M | 0.05% |
60,743
+1,656
| +3% | +$277K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
- Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
- Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
- Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
- Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
- Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.